Floatz logo

hyoscine-n-butyl bromide

Condition: Major Depressive Disorder (MDD)

Philipps University MarburgSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Condition: Major Depressive Disorder (MDD) cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

hyoscine-n-butyl bromide is also rated in:

ColicDormant
B
Indicative ·
57 / 100
View asset →
endometrial carcinomaDormant
CC
Indicative ·
44 / 100
View asset →
ovarian cancerDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →